Is now at
Argyll Park, Dixon, California
Argyll 

Home

Catabasis Pharmaceuticals to advance program targeting type 2 diabetes with $39.

Type 2 diabetes prices continue steadily to skyrocket and we need to explore new effective and safe therapeutic methods to treat the root cause of the condition, said Dr. Shoelson. Recent studies claim that salsalate may offer a fresh avenue for treatment in type 2 diabetes. Catabasis is ‘rethinking’ irritation by pairing salicylate and omega-3 fatty acids to create synergistic efficacy. This will target the inflammatory pathways that donate to the pathogenesis of several diseases, including type 2 diabetes, returning the body to homeostasis or balance thereby.‘Each one of these things converge upon this idea that low-rate of recurrence oscillations reflect the brain’s programs; they are critical really,’ Schroeder stated. ‘Understanding the oscillatory dynamics of cortex can help you think about ways to develop therapies that help the cortex find out or re-find out after damage.’.. Breakthrough research may lead to fresh potential treatments for malaria Groundbreaking research done in Singapore’s Nanyang Technical University’s Classes of Biological Sciences may lead to the advancement of more potent medicines or a vaccine meant for malaria, which is transmitted to human beings by infected mosquitoes and kills up to three million people each whole year.